Utter Christine's most recent trade in PTC Therapeutics Inc was a trade of 879 Common Stock done at an average price of $50.1 . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 50.10 per share. | 19 Feb 2025 | 879 | 63,442 (0%) | 0% | 50.1 | 44,034 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 50.12 per share. | 19 Feb 2025 | 878 | 62,564 (0%) | 0% | 50.1 | 44,009 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 44.50 per share. | 07 Jan 2025 | 1,662 | 64,321 (0%) | 0% | 44.5 | 73,959 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 45.34 per share. | 07 Jan 2025 | 1,291 | 65,983 (0%) | 0% | 45.3 | 58,534 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 14,000 | 67,274 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 14,695 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Utter Christine | SVP, CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 14,695 | 67,123 (0%) | 0% | 51 | 749,445 | Common Stock |
| PTC Therapeutics Inc | Utter Christine | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 51.53 per share. | 02 Dec 2024 | 9,919 | 57,204 (0%) | 0% | 51.5 | 511,126 | Common Stock |
| PTC Therapeutics Inc | Utter Christine | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 52.45 per share. | 02 Dec 2024 | 4,776 | 52,428 (0%) | 0% | 52.4 | 250,501 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.00 per share. | 02 Dec 2024 | 3,105 | 55,533 (0%) | 0% | 51 | 158,355 | Common Stock |
| PTC Therapeutics Inc | Utter Christine | SVP, CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 3,105 | 14,695 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 51.34 per share. | 02 Dec 2024 | 2,497 | 53,036 (0%) | 0% | 51.3 | 128,196 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 52.24 per share. | 02 Dec 2024 | 608 | 52,428 (0%) | 0% | 52.2 | 31,762 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 14,000 | 49,528 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Utter Christine | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 2,900 | 52,428 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Utter Christine | SVP, CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 27.25 per share. | 30 Jan 2024 | 318 | 35,528 (0%) | 0% | 27.3 | 8,666 | Common Stock |
| PTC Therapeutics Inc | Utter Christine | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 29.01 per share. | 08 Jan 2024 | 1,653 | 35,846 (0%) | 0% | 29.0 | 47,961 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 08 Jan 2024 | 1,188 | 37,499 (0%) | 0% | 28.6 | 34,025 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 55.05 per share. | 21 Apr 2023 | 4,321 | 38,059 (0%) | 0% | 55.1 | 237,876 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 21 Apr 2023 | 4,321 | 42,380 (0%) | 0% | 33.0 | 142,679 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 4,321 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 21 Apr 2023 | 371 | 38,430 (0%) | 0% | 33.0 | 12,250 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 371 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 55.09 per share. | 21 Apr 2023 | 351 | 38,079 (0%) | 0% | 55.1 | 19,337 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 55.65 per share. | 21 Apr 2023 | 20 | 38,059 (0%) | 0% | 55.7 | 1,113 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.45 per share. | 29 Mar 2023 | 4,688 | 42,747 (0%) | 0% | 40.5 | 189,630 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,688 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 47.80 per share. | 29 Mar 2023 | 3,247 | 39,500 (0%) | 0% | 47.8 | 155,200 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 47.78 per share. | 29 Mar 2023 | 1,441 | 38,059 (0%) | 0% | 47.8 | 68,844 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 27 Mar 2023 | 16,929 | 54,988 (0%) | 0% | 33.0 | 558,996 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2023 | 16,929 | 4,321 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2023 | 9,729 | 371 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 27 Mar 2023 | 9,729 | 47,788 (0%) | 0% | 33.0 | 321,252 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 45.42 per share. | 27 Mar 2023 | 8,780 | 38,259 (0%) | 0% | 45.4 | 398,749 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 44.72 per share. | 27 Mar 2023 | 7,949 | 47,039 (0%) | 0% | 44.7 | 355,461 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 45.38 per share. | 27 Mar 2023 | 4,954 | 38,359 (0%) | 0% | 45.4 | 224,833 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 44.71 per share. | 27 Mar 2023 | 4,475 | 43,313 (0%) | 0% | 44.7 | 200,058 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 46.01 per share. | 27 Mar 2023 | 300 | 38,059 (0%) | 0% | 46.0 | 13,803 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 27 Mar 2023 | 200 | 38,059 (0%) | 0% | 46.0 | 9,201 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 325 | 38,059 (0%) | 0% | 45.6 | 14,829 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 489 | 38,801 (0%) | 0% | 42.9 | 20,994 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 10 Jan 2023 | 417 | 38,384 (0%) | 0% | 44.4 | 18,498 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 41.66 per share. | 09 Jan 2023 | 706 | 39,290 (0%) | 0% | 41.7 | 29,409 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,000 | 39,996 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 40.38 per share. | 01 Feb 2022 | 707 | 25,405 (0%) | 0% | 40.4 | 28,549 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 313 | 26,112 (0%) | 0% | 40.0 | 12,521 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 18 Jan 2022 | 10,000 | 36,425 (0%) | 0% | 18.0 | 180,100 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 18 Jan 2022 | 10,000 | 26,425 (0%) | 0% | 44 | 440,000 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 43.50 per share. | 18 Jan 2022 | 1,428 | 26,425 (0%) | 0% | 43.5 | 62,118 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 43,500 | 43,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 11,600 | 27,853 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 38.52 per share. | 07 Jan 2022 | 747 | 16,253 (0%) | 0% | 38.5 | 28,778 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 2,657 | 21,250 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 66.00 per share. | 08 Feb 2021 | 2,657 | 16,509 (0%) | 0% | 66 | 175,362 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 08 Feb 2021 | 2,657 | 19,166 (0%) | 0% | 33.0 | 87,734 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 57.64 per share. | 01 Feb 2021 | 652 | 16,509 (0%) | 0% | 57.6 | 37,581 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 56.96 per share. | 01 Feb 2021 | 368 | 17,161 (0%) | 0% | 57.0 | 20,960 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2021 | 2,500 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 66.57 per share. | 13 Jan 2021 | 2,500 | 17,529 (0%) | 0% | 66.6 | 166,425 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 13 Jan 2021 | 2,500 | 20,029 (0%) | 0% | 18.0 | 45,025 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2021 | 788 | 0 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 66.57 per share. | 13 Jan 2021 | 788 | 17,529 (0%) | 0% | 66.6 | 52,457 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 13 Jan 2021 | 788 | 18,317 (0%) | 0% | 11.2 | 8,849 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 66.57 per share. | 13 Jan 2021 | 659 | 17,529 (0%) | 0% | 66.6 | 43,870 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 50,750 | 50,750 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 8,700 | 18,188 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 05 Jan 2021 | 316 | 9,488 (0%) | 0% | 62.4 | 19,709 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 10,625 | 26,563 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 04 Nov 2020 | 10,625 | 20,187 (0%) | 0% | 33.0 | 350,838 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 10,625 | 9,562 (0%) | 0% | 60 | 637,500 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 04 Nov 2020 | 8,055 | 17,617 (0%) | 0% | 30.9 | 248,577 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.20 per share. | 04 Nov 2020 | 8,055 | 9,562 (0%) | 0% | 60.2 | 484,911 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 8,055 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 04 Nov 2020 | 2,656 | 12,218 (0%) | 0% | 33.0 | 87,701 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 04 Nov 2020 | 2,656 | 12,218 (0%) | 0% | 33.0 | 87,701 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 2,656 | 9,562 (0%) | 0% | 60 | 159,360 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 2,656 | 39,844 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 2,656 | 37,188 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 2,656 | 23,907 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 2,656 | 9,562 (0%) | 0% | 60 | 159,360 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 04 Nov 2020 | 2,656 | 12,218 (0%) | 0% | 33.0 | 87,701 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 2,656 | 9,562 (0%) | 0% | 60 | 159,360 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 04 Nov 2020 | 2,500 | 12,062 (0%) | 0% | 18.0 | 45,025 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 2,500 | 9,562 (0%) | 0% | 60 | 150,000 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 2,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.20 per share. | 04 Nov 2020 | 1,567 | 9,562 (0%) | 0% | 60.2 | 94,333 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 04 Nov 2020 | 1,567 | 11,129 (0%) | 0% | 30.9 | 48,358 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 1,567 | 8,743 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 688 | 9,562 (0%) | 0% | 60 | 41,280 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 04 Nov 2020 | 688 | 10,250 (0%) | 0% | 30.9 | 21,232 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 688 | 8,055 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 355 | 9,562 (0%) | 0% | 60 | 21,300 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 04 Nov 2020 | 355 | 9,917 (0%) | 0% | 18.0 | 6,394 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 355 | 15,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 05 Oct 2020 | 2,500 | 12,062 (0%) | 0% | 18.0 | 45,025 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 50.08 per share. | 05 Oct 2020 | 2,500 | 9,562 (0%) | 0% | 50.1 | 125,208 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 2,500 | 15,355 | - | - | Stock Option (Right to Buy) |